Prescription Rates for Antiplatelet Therapy (APT) in Coronary Artery Disease (CAD) – What Benchmark are We Aiming at in Continuing Medical Education (CME)?
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of European CME
- Vol. 9 (1)
Abstract
Physicians always aim to improve their patients’ health. CME should be designed not only to provide knowledge transfer, but also to influence clinical decision-making and to close performance gaps. In aretrospective study we analysed prescription rates for APT in 254,932 CAD patients (male: 64.4%), treated in atotal of 3,405 practices in 2019 in aDMP in the region of North Rhine, Germany. Analyses were run for the whole study population stratified by sex as well as for subgroups of patients suffering from myocardial infarction/acute coronary syndrome, or who have been treated with percutaneous coronary intervention or bypass surgery. Patients mean age was 72.7 ± 11.2 years (mean ± 1SD), mean duration of DMP participation was 7.2 ± 4.7 years, and mean cumulative number of DMP visits was 27 ± 17. APT prescription rates were 85.0% in male and 78.8% in female CAD patients. In subgroups of male CAD patients APT prescription rates were between 89.7% and 92.8%, in the same subgroups of female CAD patients the corresponding rates were between 87.8% and 92.0%. Rates for amissing APT prescription per practice were between .0044% and .0062% for male and female CAD patients, respectively. Rates for amissing APT prescription per practice and DMP visit were .0002% for both sexes. These results suggest that a DMP can achieve high attainment rates for APT in CAD. To further improve attainment rates, consideration of absolute numbers of eligible patients per practice or physician is probably more appropriate than expression of performance as percentage values. This is especially true if attainment rates show substantial variations between subgroups, if subgroups show substantial variation in size, if attainment rates are already in the magnitude of 80% or higher, and if there are disparities in the evidence base underlying treatment recommendations related to subgroups.Keywords
This publication has 50 references indexed in Scilit:
- Trauma registry record linkage: methodological approach to benefit from complementary data using the example of the German Pelvic Injury Register and the TraumaRegister DGU®BMC Medical Research Methodology, 2013
- How accurate is the reporting of stroke in hospital discharge data? A pilot validation study using a population-based stroke registry as controlJournal of Neurology, 2012
- The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trialsJournal of the American Medical Informatics Association, 2012
- Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD)European Heart Journal, 2011
- Trauma Patients Without a Trauma Diagnosis: The Data Gap at a Level One Trauma CenterJournal of Trauma: Injury, Infection & Critical Care, 2009
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Achieving desired results and improved outcomes: Integrating planning and assessment throughout learning activitiesJournal of Continuing Education in the Health Professions, 2009
- Cardiovascular Health DisparitiesMedical Care Research and Review, 2007
- Gender Differences in Aspirin use Among Adults With Coronary Heart Disease in the United StatesJournal of General Internal Medicine, 2007
- Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectorisThe Lancet, 1992